Novel Chemical Suppressors of Long QT Syndrome Identified by an In Vivo Functional Screen
Page 1 of 1
Novel Chemical Suppressors of Long QT Syndrome Identified by an In Vivo Functional Screen
Jon Moulton Mon Nov 29, 2010 11:59 am
Peal DS, Mills RW, Lynch SN, Mosley JM, Lim E, Ellinor PT, January CT, Peterson RT, Milan DJ. Novel Chemical Suppressors of Long QT Syndrome Identified by an In Vivo Functional Screen. Circulation. 2010 Nov 15. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay
» Characterization of a novel KRAS mutation identified in Noonan syndrome
» A Loss of Function Screen of Identified Genome-Wide Association Study Loci Reveals New Genes Controlling Hematopoiesis
» Chemical and genetic rescue of an ep300 knockdown model for Rubinstein Taybi syndrome in zebrafish
» In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
» Characterization of a novel KRAS mutation identified in Noonan syndrome
» A Loss of Function Screen of Identified Genome-Wide Association Study Loci Reveals New Genes Controlling Hematopoiesis
» Chemical and genetic rescue of an ep300 knockdown model for Rubinstein Taybi syndrome in zebrafish
» In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|